Retinoblastoma protein purification and transduction of retina and retinoblastoma cells using improved alphavirus vectors

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 9, 2004, Pages 3320-3329

  DiCiommo, David P ^a,c,d,e   Duckett, Allison ^a,c,d   Burcescu, Irina ^b,c,d   Bremner, Rod ^b,c,d,e   Gallie, Brenda L ^a,c,d  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; RETINOBLASTOMA PROTEIN; VIRUS VECTOR;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; CELL STRAIN BHK; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; RETINA CELL; SEMLIKI FOREST ALPHAVIRUS;

ALPHAVIRUS; ANIMALS; CELL CYCLE PROTEINS; CELL LINE; CRICETINAE; DNA; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; GENETIC VECTORS; HUMANS; MICE; REPLICON; RETINA; RETINAL NEOPLASMS; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN; TOGAVIRIDAE; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; VIRAL PROTEINS;

EID: 4344572156     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0140     Document Type: Article

References (59)

1. DiCiommo D, Gallie BL, Bremner R. Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. Semin Cancer Biol. 2000;10:255-269.
2. Morris EJ, Dyson NJ. Retinoblastoma protein partners. Adv Cancer Res. 2001;82:1-54.
3. Stevaux O, Dyson NJ. A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol. 2002;14:684-691.
4. Young AP, Longmore GD. Differences in stability of repressor complexes at promoters underlie distinct roles for Rb family members. Oncogene. 2004;23:814-823.
5. Lee JO, Russo AA, Pavletich NP. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature. 1998;391:859-865.
6. Brown VD, Gallie BL. The B-domain lysine patch of pRB is required for binding to large T antigen and release of E2F by phosphorylation. Mol Cell Biol. 2002;22:1390-1401.
7. Wang NP, Qian YW, Chung AE, Lee WH, Lee EY. Expression of the human retinoblastoma gene product pp110RB in insect cells using the baculovirus system. Cell Growth Differ. 1990;1:429-437.
8. Savoysky E, Suzuki M, Tamai K, et al. Efficient purification of a full length and biochemically active p110Rb, the retinoblastoma gene product. Biochem Biophys Res Commun. 1992;187:697-702.
9. Martin KR, Klein RL, Quigley HA. Gene delivery to the eye using adeno-associated viral vectors. Methods. 2002;28:267-275.
10. Chaum E, Hatton MP. Gene therapy for genetic and acquired retinal diseases. Surv Ophthalmol. 2002;47:449-469.
11. Muncaster MM, Cohen BL, Phillips RA, Gallie BL. Failure of RB1 to reverse the malignant phenotype of human tumor cell lines. Cancer Res. 1992;52:654-661.
12. Cashman SM, Sadowski SL, Morris DJ, Frederick J, Kumar-Singh R. Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptors: implications for gene therapy. Mol Ther. 2002;6:813-823.
13. White JB, Taylor RE, Pittler SJ. Reproducible high efficiency gene transfer into Y79 retinoblastoma cells using adenofection. J Neurosci Methods. 2001;106:1-7.
14. Chang MW, Barr E, Seltzer J, et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 1995;267:518-522.
15. Park DS, Morris EJ, Bremner R, et al. Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage. J Neurosci. 2000;20:3104-3114.
16. Zhu X, Pattenden S, Bremner R. pRB is required for interferon-γ induction of the MHC class II Aβ gene. Oncogene. 1999;18:4940-4947.
17. Gallie BL, Trogadis J, Han L-P. Retinoblastoma. In: Masters J, ed. Human Cell Culture. 1999:361-374.
18. Massie B, Dionne J, Lamarche N, Fleurent J, Langelier Y. Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently. Biotechnology. 1995;13:602-608.
19. Massie B, Couture F, Lamoureux L, et al. Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette. J Virol. 1998;72:2289-2296.
20. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer. 1994;57:353-361.
21. Lundstrom K. Latest development in viral vectors for gene therapy. Trends Biotechnol. 2003;21:117-122.
22. Ehrengruber MU, Hennou S, Bueler H, Naim HY, Deglon N, Lundstrom K. Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest virus, adenovirus, adeno-associated virus, lentivirus, and measles virus. Mol Cell Neurosci. 2001;17:855-871.
23. Glasgow GM, McGee MM, Sheahan BJ, Atkins GJ. Death mechanisms in cultured cells infected by Semliki Forest virus. J Gen Virol. 1997;78:1559-1563.
24. Wahlfors JJ, Zullo SA, Loimas S, Nelson DM, Morgan RA. Evaluation of recombinant alphaviruses as vectors in gene therapy. Gene Ther. 2000;7:472-480.
25. Ehrengruber MU, Lundstrom K, Schweitzer C, Heuss C, Schlesinger S, Gahwiler BH. Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures. Proc Natl Acad Sci USA. 1999;96:7041-7046.
26. Owe-Larsson B, Berglund M, Kristensson K, et al. Perturbation of the synaptic release machinery in hippocampal neurons by overexpression of SNAP-25 with the Semliki Forest virus vector. Eur J Neurosci. 1999;11:1981-1987.
27. Liljestrom P, Garoff H. A new generation of animal expression vectors based on the Semliki Forest virus replicon. Biotechnology. 1991;9:1356-1361.
28. DiCiommo DP, Bremner R. Rapid, high level protein production using DNA-based Semliki Forest virus vectors. J Biol Chem. 1998; 273:18060-18066.
29. Herweijer H, Latendresse JS, Williams P, et al. A plasmid-based self-amplifying Sindbis virus vector. Hum Gene Ther. 1995;6: 1161-1167.
30. Dubensky TWJ, Driver DA, Polo JM, et al. Sindbis virus DNA-based expression vector: utility for in vitro and in vivo gene transfer. J Virol. 1996;70:508-519.
31. Kohno A, Emi N, Kasai M, Tanimoto M, Salto H. Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death. Gene Ther. 1998;5:415-418.
32. Daniels MP, Hamprecht B. The ultrastructure of neuroblastoma glioma somatic cell hybrids. J Cell Biol. 1974;63:691-699.
33. Bremner R, Cohen BL, Sopta M, et al. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol Cell Biol. 1995;15:3256-3265.
34. Morgenstern JP, Land H. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res. 1990; 18:1068.
35. Sambrook J. Molecular Cloning: A Laboratory Manual: Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1987.
36. Strauss JH, Strauss EG. The alphaviruses: gene expression, replication and evolution. Microbiol Rev. 1994;58:491-562.
37. Ohno K, Sawai K, Iijima Y, Levin B, Meruelo D. Cell-specific targeting of sindbis virus vectors displaying IgG-binding domains of protein A. Nat Biotechnol. 1997;15:763-767.
38. Richardson CD, Vance DE. Biochemical evidence that Semliki Forest virus obtains its envelope from the plasma membrane of the host cell. J Biol Chem. 1976;251:5544-5550.
39. Polo JM, Belli BA, Driver DA, et al. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. Proc Natl Acad Sci USA. 1999;96:4598-4603.
40. Sjoberg EM, Suomalainen M, Garoff H. A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene. Biotechnology. 1994; 12:1127-1131.
41. Daemen T, Regis J, Holtrop M, Wilschut J. Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7. Gene Ther. 2002;9:85-94.
42. Netzer WJ, Hartl FU. Recombination of protein domains facilitated by co-translational folding in eukaryotes (see comments). Nature. 1997;388:343-349.
43. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 1999;285:1569-1572.
44. Chow KN, Dean DC. Domains A and B in the Rb pocket interact to form a transcriptional repressor motif. Mol Cell Biol. 1996;16: 4862-4868.
45. Sparrow JR, Hicks D, Barnstable CJ. Cell commitment and differentiation in explants of embryonic rat neural retina: comparison with the developmental potential of dissociated retina. Brain Res Dev Brain Res. 1990;51:69-84.
46. Seigel GM. The golden age of retinal cell culture. Mol Vis. 1999; 5:4.
47. Ross JF, Liu X, Dynlacht BD. Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein. Mol Cell. 1999;3:195-205.
48. Wei S, Xu T, Ashery U, et al. Exocytotic mechanism studied by truncated and zero layer mutants of the C-terminus of SNAP-25. EMBO J. 2000;19:1279-1289.
49. Takamori S, Rhee JS, Rosenmund C, Jahn R. Identification of differentiation-associated brain-specific phosphate transporter as a second vesicular glutamate transporter (VGLUT2). J Neurosci. 2001;21:RC182(1-6).
50. Chuang JL, Schleef RR. Recombinant Semliki Forest virus enhanced plasminogen activator inhibitor 1 expression and storage in the megakaryocytic cell line MEG-01. J Cell Biochem. 2001;82: 277-289.
51. Perri S, Driver DA, Gardner JP, et al. Replicon vectors derived from Sindbis virus and Semliki forest virus that establish persistent replication in host cells. J Virol. 2000;74:9802-9807.
52. Lundstrom K, Rotmann D, Hermann D, Schneider EM, Ehrengruber MU. Novel mutant Semliki Forest virus vectors: gene expression and localization studies in neuronal cells. Histochem Cell Biol. 2001;115:83-91.
53. Lundstrom K, Abenavoli A, Malgaroli A, Ehrengruber MU. Novel Semliki Forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-term enhancement of transgene expression. Mol Ther. 2003;7:202-209.
54. Tseng JC, Levin B, Hirano T, Yee H, Pampeno C, Meruelo D. In vivo antitumor activity of Sindbis viral vectors. J Natl Cancer Inst. 2002;94:1790-1802.
55. Tseng JC, Levin B, Hurtado A, et al. Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol. 2004;22: 70-77.
56. Squire J, Gallie BL, Phillips RA. A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. Hum Genet. 1985;70:291-301.
57. Gallie BL, Campbell C, Devlin H, Duckett A, Squire JA. Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res. 1999;59:1731s-1735s.
58. Chen D, Gallie BL, Squire JA. Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet. 2001;129:57-63.
59. Chen D, Pajovic S, Duckett A, Brown VD, Squire JA, Gallie BL. Genomic amplification in retinoblastoma narrowed to 0.6 megabase on chromosome 6p containing a kinesin-like gene, RBKIN. Cancer Res. 2002;62:967-971.